Results 221 to 230 of about 81,801 (247)
Some of the next articles are maybe not open access.

Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives

Cardiovascular & Hematological Disorders-Drug Targets, 2013
SERPINA1, α-antitrypsin (AAT) is an acute phase protein, a member of the serpin (serine protease inhibitor) super family and one of the most abundant protease inhibitors in the circulation. The clinical importance of AAT is emphasized in persons with inherited AAT deficiency who exhibit high risk of developing early onset pulmonary emphysema, neonatal ...
Janciauskiene, Sabina, Welte, Tobias
openaire   +2 more sources

Sensor-Augmented Pump Therapy at 36 Months

Diabetes Technology & Therapeutics, 2012
Background: This follow-up study investigates the metabolic and psychosocial effects of sensor-augmented pump (SAP) therapy in adults with type 1 diabetes 36 months after therapy start. Subjects and Methods: We invited all 24 Danish ...
Schmidt, Signe, Nørgaard, Kirsten
openaire   +3 more sources

Augmented Therapy with Online Support Groups

2019
Support groups are often formed in hospitals and clinics to enable group therapy. A support group consists of patients suffering from a same disease. Manual formation of support groups has three drawbacks. First, it is “local”, i.e., a support group for a specific type of cancer in a local hospital may contain patients with different symptoms and ...
openaire   +1 more source

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy

2017
Subjects with alpha-1 antitrypsin deficiency who develop pulmonary disease are managed following general treatment guidelines, including disease management interventions. In addition, administration of intravenous infusions of alpha-1 proteinase inhibitor (augmentation therapy) at regular schedules is a specific therapy for individuals with AATD with ...
Michael, Campos, Jorge, Lascano
openaire   +2 more sources

Caffeine augmentation in electroconvulsive therapy

Pharmacopsychiatry, 2022
Else Schneider, Annette Brühl
openaire   +1 more source

AREsTA - An Augmented Reality Exposure Therapy Application

2023 6th Experiment@ International Conference (exp.at'23), 2023
Daniel Matias   +2 more
openaire   +1 more source

Augmentation Therapy Nowadays: Con

Archivos de Bronconeumología (English Edition), 2018
openaire   +2 more sources

A Review of the Use of Augmentation Therapy for the Treatment of Resistant Depression: Implications for the Clinician

Australian and New Zealand Journal of Psychiatry, 1997
George Johnson, Isaac Schweitzer
exaly  

Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data

Cognitive Behaviour Therapy, 2015
Jasper Smits   +2 more
exaly  

Home - About - Disclaimer - Privacy